BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 2678002)

  • 41. Molecular biology of chronic myelogenous leukemia.
    Dreazen O; Canaani E; Gale RP
    Semin Hematol; 1988 Jan; 25(1):35-48. PubMed ID: 3279514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.
    Collins SJ
    J Clin Invest; 1986 Nov; 78(5):1392-6. PubMed ID: 3021820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BCR gene recombines with genomically distinct sites on band 11Q13 in complex BCR-ABL translocations of chronic myeloid leukemia.
    Morris C; Jeffs A; Smith T; McDonald M; Board P; Kennedy M; Fitzgerald P
    Oncogene; 1996 Feb; 12(3):677-85. PubMed ID: 8637725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular analysis of Philadelphia-positive childhood chronic myeloid leukemia.
    Fioretos T; Heim S; Garwicz S; Ludvigsson J; Mitelman F
    Leukemia; 1992 Jul; 6(7):723-5. PubMed ID: 1625493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Translocation of c-abl oncogene and PDGFB (c-sis) gene in a case of CML with 46,XY, t(22;22).
    Gradl G; Tesch H; Schwieder G; Wagner T; Fonatsch C
    Blut; 1989 Jun; 58(6):279-85. PubMed ID: 2660925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CGG-repeat polymorphism of the BCR gene rules out predisposing alleles leading to the Philadelphia chromosome.
    Riggins GJ; Sherman SL; Phillips CN; Stock W; Westbrook CA; Warren ST
    Genes Chromosomes Cancer; 1994 Feb; 9(2):141-4. PubMed ID: 7513545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular biology of the Philadelphia positive leukaemias.
    Morgan GJ; Wiedemann LM
    Recenti Prog Med; 1989 Oct; 80(10):508-19. PubMed ID: 2690217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Hooberman AL; Carrino JJ; Leibowitz D; Rowley JD; Le Beau MM; Arlin ZA; Westbrook CA
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4259-63. PubMed ID: 2498881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fusion of the bcr and the c-abl genes in Ph'-positive acute lymphocytic leukemia with no rearrangement in the breakpoint cluster region.
    ar-Rushdi A; Negrini M; Kurzrock R; Huebner K; Croce CM
    Oncogene; 1988 Apr; 2(4):353-7. PubMed ID: 3283653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.
    Allen PB; Morgan GJ; Wiedemann LM
    Baillieres Clin Haematol; 1992 Oct; 5(4):897-930. PubMed ID: 1308169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia.
    Hirsch-Ginsberg C; LeMaistre AC; Kantarjian H; Talpaz M; Cork A; Freireich EJ; Trujillo JM; Lee MS; Stass SA
    Blood; 1990 Sep; 76(6):1214-9. PubMed ID: 2205309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
    Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
    Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies of BCR rearrangements in Philadelphia-positive acute leukemia.
    Hillion J; Flexor MA; Larsen CJ; Berger R
    Cancer Genet Cytogenet; 1991 Feb; 51(2):259-67. PubMed ID: 1993310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL).
    Clark SS; McLaughlin J; Timmons M; Pendergast AM; Ben-Neriah Y; Dow LW; Crist W; Rovera G; Smith SD; Witte ON
    Science; 1988 Feb; 239(4841 Pt 1):775-7. PubMed ID: 3422516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Strategy for breakpoint cluster region analysis in chronic myelocytic leukemia in a routine clinical laboratory.
    Haber LM; Childs CC; Hirsch-Ginsberg C; Nellis K; Kantarjian HM; Cork A; Trujillo JM; Stass SA
    Am J Clin Pathol; 1990 Dec; 94(6):762-7. PubMed ID: 2244594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-range mapping of the Philadelphia chromosome by pulsed-field gel electrophoresis.
    Westbrook CA; Rubin CM; Carrino JJ; Le Beau MM; Bernards A; Rowley JD
    Blood; 1988 Mar; 71(3):697-702. PubMed ID: 3422829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new chromosomal breakpoint in Ph positive, bcr negative chronic myelogenous leukemia. Report of a case.
    Negrini M; Tallarico A; Pazzi I; Castagnoli A; Cuneo A; Castoldi GL
    Cancer Genet Cytogenet; 1992 Jul; 61(1):11-3. PubMed ID: 1353407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.
    Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K
    Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960
    [No Abstract]   [Full Text] [Related]  

  • 59. [Philadelphia-positive ALL with rearrangement of the 1st intron of the BCR gene].
    Valiente A; Escudero A; Benítez J
    Sangre (Barc); 1991 Dec; 36(6):505-8. PubMed ID: 1812584
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ph1-chromosome positive acute lymphoblastic leukemia: is t(9;22) the initial abnormality?
    Aurer I; Sparkes RS; Schiller G; Gale RP
    Am J Hematol; 1993 May; 43(1):61-2. PubMed ID: 8317466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.